Annual CFO
$16.70 M
+$130.74 M+114.65%
December 31, 2023
Summary
- As of February 24, 2025, ACAD annual cash flow from operations is $16.70 million, with the most recent change of +$130.74 million (+114.65%) on December 31, 2023.
- During the last 3 years, ACAD annual CFO has risen by +$152.87 million (+112.27%).
- ACAD annual CFO is now -34.06% below its all-time high of $25.33 million, reached on December 31, 2000.
Performance
ACAD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$63.25 M
+$38.23 M+152.85%
September 30, 2024
Summary
- As of February 24, 2025, ACAD quarterly cash flow from operations is $63.25 million, with the most recent change of +$38.23 million (+152.85%) on September 30, 2024.
- Over the past year, ACAD quarterly CFO has increased by +$122.20 million (+207.28%).
- ACAD quarterly CFO is now -25.93% below its all-time high of $85.39 million, reached on December 31, 2023.
Performance
ACAD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$202.73 M
+$122.20 M+151.75%
September 30, 2024
Summary
- As of February 24, 2025, ACAD TTM cash flow from operations is $202.73 million, with the most recent change of +$122.20 million (+151.75%) on September 30, 2024.
- Over the past year, ACAD TTM CFO has increased by +$295.27 million (+319.07%).
- ACAD TTM CFO is now at all-time high.
Performance
ACAD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ACAD Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +114.7% | +207.3% | +319.1% |
| 3 y3 years | +112.3% | +470.6% | +255.9% |
| 5 y5 years | +110.0% | +435.5% | +234.1% |
ACAD Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.3% | -25.9% | +182.9% | at high | +242.9% |
| 5 y | 5-year | at high | +111.0% | -25.9% | +182.9% | at high | +234.1% |
| alltime | all time | -34.1% | +107.7% | -25.9% | +182.9% | at high | +181.4% |
ACADIA Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $63.25 M(+152.9%) | $202.73 M(+151.8%) |
| Jun 2024 | - | $25.01 M(-14.0%) | $80.53 M(+26.4%) |
| Mar 2024 | - | $29.08 M(-65.9%) | $63.71 M(+281.5%) |
| Dec 2023 | $16.70 M(-114.6%) | $85.39 M(-244.8%) | $16.70 M(-118.0%) |
| Sep 2023 | - | -$58.95 M(-818.9%) | -$92.54 M(+169.7%) |
| Jun 2023 | - | $8.20 M(-145.7%) | -$34.31 M(-38.3%) |
| Mar 2023 | - | -$17.93 M(-24.8%) | -$55.64 M(-51.2%) |
| Dec 2022 | -$114.03 M(-9.3%) | -$23.85 M(+3181.2%) | -$114.03 M(+0.6%) |
| Sep 2022 | - | -$727.00 K(-94.5%) | -$113.30 M(-12.6%) |
| Jun 2022 | - | -$13.13 M(-82.8%) | -$129.64 M(-8.6%) |
| Mar 2022 | - | -$76.33 M(+230.1%) | -$141.84 M(+12.9%) |
| Dec 2021 | -$125.66 M(-7.7%) | -$23.12 M(+35.5%) | -$125.66 M(-3.4%) |
| Sep 2021 | - | -$17.06 M(-32.6%) | -$130.03 M(-4.2%) |
| Jun 2021 | - | -$25.33 M(-57.9%) | -$135.76 M(-7.8%) |
| Mar 2021 | - | -$60.15 M(+118.8%) | -$147.31 M(+8.2%) |
| Dec 2020 | -$136.17 M(-9.9%) | -$27.49 M(+20.6%) | -$136.17 M(-1.6%) |
| Sep 2020 | - | -$22.79 M(-38.2%) | -$138.38 M(+2.9%) |
| Jun 2020 | - | -$36.88 M(-24.7%) | -$134.44 M(-1.1%) |
| Mar 2020 | - | -$49.00 M(+65.0%) | -$135.96 M(-10.0%) |
| Dec 2019 | -$151.13 M(-9.8%) | -$29.71 M(+57.6%) | -$151.13 M(-5.8%) |
| Sep 2019 | - | -$18.85 M(-50.9%) | -$160.50 M(-12.7%) |
| Jun 2019 | - | -$38.40 M(-40.2%) | -$183.93 M(-1.3%) |
| Mar 2019 | - | -$64.17 M(+64.2%) | -$186.41 M(+11.3%) |
| Dec 2018 | -$167.47 M(-23.1%) | -$39.08 M(-7.6%) | -$167.47 M(+5.8%) |
| Sep 2018 | - | -$42.28 M(+3.4%) | -$158.29 M(-9.2%) |
| Jun 2018 | - | -$40.88 M(-9.6%) | -$174.41 M(-9.4%) |
| Mar 2018 | - | -$45.24 M(+51.3%) | -$192.43 M(-11.6%) |
| Dec 2017 | -$217.76 M(+4.5%) | -$29.89 M(-48.8%) | -$217.76 M(-12.6%) |
| Sep 2017 | - | -$58.40 M(-0.8%) | -$249.05 M(+3.8%) |
| Jun 2017 | - | -$58.90 M(-16.5%) | -$239.91 M(+0.9%) |
| Mar 2017 | - | -$70.56 M(+15.3%) | -$237.76 M(+14.1%) |
| Dec 2016 | -$208.41 M(+71.1%) | -$61.19 M(+24.2%) | -$208.41 M(+14.5%) |
| Sep 2016 | - | -$49.26 M(-13.2%) | -$181.94 M(+10.6%) |
| Jun 2016 | - | -$56.74 M(+37.7%) | -$164.53 M(+19.5%) |
| Mar 2016 | - | -$41.21 M(+18.7%) | -$137.66 M(+13.0%) |
| Dec 2015 | -$121.80 M(+83.3%) | -$34.72 M(+9.0%) | -$121.80 M(+16.1%) |
| Sep 2015 | - | -$31.85 M(+6.6%) | -$104.87 M(+15.9%) |
| Jun 2015 | - | -$29.87 M(+17.9%) | -$90.50 M(+16.6%) |
| Mar 2015 | - | -$25.35 M(+42.4%) | -$77.60 M(+16.8%) |
| Dec 2014 | -$66.43 M(+109.1%) | -$17.80 M(+1.8%) | -$66.43 M(+12.8%) |
| Sep 2014 | - | -$17.48 M(+3.0%) | -$58.90 M(+15.7%) |
| Jun 2014 | - | -$16.97 M(+19.6%) | -$50.89 M(+29.3%) |
| Mar 2014 | - | -$14.18 M(+38.2%) | -$39.37 M(+23.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$31.77 M(+46.9%) | -$10.27 M(+8.3%) | -$31.77 M(+14.3%) |
| Sep 2013 | - | -$9.47 M(+74.0%) | -$27.80 M(+17.6%) |
| Jun 2013 | - | -$5.44 M(-17.3%) | -$23.63 M(+2.8%) |
| Mar 2013 | - | -$6.58 M(+4.6%) | -$22.99 M(+6.3%) |
| Dec 2012 | -$21.63 M(+8.7%) | -$6.30 M(+18.7%) | -$21.63 M(+4.6%) |
| Sep 2012 | - | -$5.31 M(+10.5%) | -$20.67 M(+5.8%) |
| Jun 2012 | - | -$4.80 M(-8.2%) | -$19.54 M(-2.4%) |
| Mar 2012 | - | -$5.23 M(-2.0%) | -$20.02 M(+0.6%) |
| Dec 2011 | -$19.90 M(+85.9%) | -$5.34 M(+27.9%) | -$19.90 M(+99.9%) |
| Sep 2011 | - | -$4.17 M(-21.0%) | -$9.96 M(+19.9%) |
| Jun 2011 | - | -$5.28 M(+3.4%) | -$8.30 M(-11.3%) |
| Mar 2011 | - | -$5.11 M(-210.9%) | -$9.36 M(-12.6%) |
| Dec 2010 | -$10.70 M(-22.0%) | $4.60 M(-282.6%) | -$10.70 M(-55.6%) |
| Sep 2010 | - | -$2.52 M(-60.2%) | -$24.08 M(-27.5%) |
| Jun 2010 | - | -$6.33 M(-1.8%) | -$33.22 M(+382.1%) |
| Mar 2010 | - | -$6.45 M(-26.5%) | -$6.89 M(-49.8%) |
| Dec 2009 | -$13.73 M(-78.8%) | -$8.77 M(-24.8%) | -$13.73 M(-20.3%) |
| Sep 2009 | - | -$11.66 M(-158.3%) | -$17.23 M(-19.5%) |
| Jun 2009 | - | $20.00 M(-250.5%) | -$21.41 M(-62.8%) |
| Mar 2009 | - | -$13.29 M(+8.3%) | -$57.61 M(-11.2%) |
| Dec 2008 | -$64.87 M(+18.1%) | -$12.27 M(-22.5%) | -$64.87 M(-2.4%) |
| Sep 2008 | - | -$15.84 M(-2.2%) | -$66.47 M(+4.2%) |
| Jun 2008 | - | -$16.21 M(-21.1%) | -$63.76 M(+4.1%) |
| Mar 2008 | - | -$20.55 M(+48.2%) | -$61.25 M(+11.5%) |
| Dec 2007 | -$54.93 M(+32.6%) | -$13.87 M(+5.5%) | -$54.93 M(+2.5%) |
| Sep 2007 | - | -$13.14 M(-4.0%) | -$53.60 M(+2.0%) |
| Jun 2007 | - | -$13.69 M(-3.7%) | -$52.56 M(+10.3%) |
| Mar 2007 | - | -$14.22 M(+13.4%) | -$47.68 M(+15.1%) |
| Dec 2006 | -$41.42 M(+104.4%) | -$12.54 M(+3.6%) | -$41.42 M(+15.3%) |
| Sep 2006 | - | -$12.11 M(+37.5%) | -$35.91 M(+19.4%) |
| Jun 2006 | - | -$8.80 M(+10.5%) | -$30.07 M(+7.5%) |
| Mar 2006 | - | -$7.96 M(+13.2%) | -$27.96 M(+38.0%) |
| Dec 2005 | -$20.26 M(-2.1%) | -$7.03 M(+12.3%) | -$20.26 M(+1.7%) |
| Sep 2005 | - | -$6.26 M(-6.4%) | -$19.93 M(+5.7%) |
| Jun 2005 | - | -$6.70 M(+2398.5%) | -$18.85 M(+10.5%) |
| Mar 2005 | - | -$268.00 K(-96.0%) | -$17.06 M(-17.6%) |
| Dec 2004 | -$20.69 M(+110.8%) | -$6.70 M(+29.3%) | -$20.69 M(+47.9%) |
| Sep 2004 | - | -$5.19 M(+5.8%) | -$13.99 M(+58.9%) |
| Jun 2004 | - | -$4.90 M(+25.6%) | -$8.80 M(+125.6%) |
| Mar 2004 | - | -$3.90 M | -$3.90 M |
| Dec 2003 | -$9.82 M(+6.2%) | - | - |
| Dec 2002 | -$9.24 M(-136.5%) | - | - |
| Dec 2000 | $25.33 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual CFO year-on-year change?
- What is ACADIA Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly CFO year-on-year change?
- What is ACADIA Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM CFO year-on-year change?
What is ACADIA Pharmaceuticals annual cash flow from operations?
The current annual CFO of ACAD is $16.70 M
What is the all time high annual CFO for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual cash flow from operations is $25.33 M
What is ACADIA Pharmaceuticals annual CFO year-on-year change?
Over the past year, ACAD annual cash flow from operations has changed by +$130.74 M (+114.65%)
What is ACADIA Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ACAD is $63.25 M
What is the all time high quarterly CFO for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly cash flow from operations is $85.39 M
What is ACADIA Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ACAD quarterly cash flow from operations has changed by +$122.20 M (+207.28%)
What is ACADIA Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ACAD is $202.73 M
What is the all time high TTM CFO for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM cash flow from operations is $202.73 M
What is ACADIA Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ACAD TTM cash flow from operations has changed by +$295.27 M (+319.07%)